Can methotrexate reduce the renal toxicity of parenteral gold?

Urban-rural disparities in old-age mortality vary systematically with age: evidence from Germany and England & Wales.

Public health·2022

The influence of the SARS-CoV-2 lockdown on patients with inflammatory rheumatic diseases on their adherence to immunomodulatory medication: a cross sectional study over 3 months in Germany.

Rheumatology (Oxford, England)·2021

[A cross sectional study on patients with inflammatory rheumatic diseases in terms of their compliance to their immunsuppressive medication during COVID-19 pandemic].

Zeitschrift fur Rheumatologie·2020

[Which patients with rheumatoid arthritis do not receive DMARD treatment? Analysis of data from the German Collaborative Arthritis Centers].

Zeitschrift fur Rheumatologie·2019

Different risk profiles of biologic agents for new-onset psoriasis in patients with rheumatoid arthritis.

Seminars in arthritis and rheumatism·2019

[S2e guideline: treatment of rheumatoid arthritis with disease-modifying drugs].

Zeitschrift fur Rheumatologie·2018

Rethinking Anti-CD20 Therapies: From Fixed to Precision Dosing.

The Journal of rheumatology·2026

Longitudinal comparison of treat-to-target states and clinical outcomes in patients with late-onset versus early-onset systemic lupus erythematosus.

The Journal of rheumatology·2026

Remission rates of patients with axial spondyloarthritis in a tertiary care center.

The Journal of rheumatology·2026

Uncovering heterogeneous health burden in axial spondyloarthritis through latent class analysis of the ASAS health index.

The Journal of rheumatology·2026

Mendelian randomisation for rheumatology: beyond hype-what it's good for, what it can't do, and how to read it critically.

The Journal of rheumatology·2026

Juvenile Arthritis Quality of Life Questionnaire Responder Metrics in Juvenile Idiopathic Arthritis: Clarifying Health-Related Quality of Life Changes Across Treatment Eras.

The Journal of rheumatology·2026

Treatment with CFTR modulators and subsequent remission of AA amyloidosis.

Clinical kidney journal·2026

Correction: Targeting oxidized phosphatidylcholines in SOD1-associated ALS: therapeutic potential of PC-OxPL-VecTab®.

Frontiers in neuroscience·2026

Comparison of Peg-INF plus TDF versus TDF Monotherapy in Indeterminate-phase Chronic Hepatitis B Patients with High HBsAg levels, HBeAg-negative status, and Normal ALT Levels.

Journal of clinical and translational hepatology·2026

Novel and Emerging Therapies for Childhood-Onset Movement Disorders.

Movement disorders : official journal of the Movement Disorder Society·2026

Implementation of soluble CD38 in blood crossmatching for patients on anti-CD38 therapy: A single-center experience.

Transfusion·2026

FAP+ pericyte-like cells promote monocyte differentiation into tumor-associated macrophages in glioblastoma.

Experimental & molecular medicine·2026

Related Experiment Videos

Can methotrexate reduce the renal toxicity of parenteral gold?

Related Concept Videos

Urban-rural disparities in old-age mortality vary systematically with age: evidence from Germany and England & Wales.

The influence of the SARS-CoV-2 lockdown on patients with inflammatory rheumatic diseases on their adherence to immunomodulatory medication: a cross sectional study over 3 months in Germany.

[A cross sectional study on patients with inflammatory rheumatic diseases in terms of their compliance to their immunsuppressive medication during COVID-19 pandemic].

[Which patients with rheumatoid arthritis do not receive DMARD treatment? Analysis of data from the German Collaborative Arthritis Centers].

Different risk profiles of biologic agents for new-onset psoriasis in patients with rheumatoid arthritis.

[S2e guideline: treatment of rheumatoid arthritis with disease-modifying drugs].

Rethinking Anti-CD20 Therapies: From Fixed to Precision Dosing.

Longitudinal comparison of treat-to-target states and clinical outcomes in patients with late-onset versus early-onset systemic lupus erythematosus.

Remission rates of patients with axial spondyloarthritis in a tertiary care center.

Uncovering heterogeneous health burden in axial spondyloarthritis through latent class analysis of the ASAS health index.

Mendelian randomisation for rheumatology: beyond hype-what it's good for, what it can't do, and how to read it critically.

Juvenile Arthritis Quality of Life Questionnaire Responder Metrics in Juvenile Idiopathic Arthritis: Clarifying Health-Related Quality of Life Changes Across Treatment Eras.

Treatment with CFTR modulators and subsequent remission of AA amyloidosis.

Correction: Targeting oxidized phosphatidylcholines in SOD1-associated ALS: therapeutic potential of PC-OxPL-VecTab®.

Comparison of Peg-INF plus TDF versus TDF Monotherapy in Indeterminate-phase Chronic Hepatitis B Patients with High HBsAg levels, HBeAg-negative status, and Normal ALT Levels.

Novel and Emerging Therapies for Childhood-Onset Movement Disorders.

Implementation of soluble CD38 in blood crossmatching for patients on anti-CD38 therapy: A single-center experience.

FAP+ pericyte-like cells promote monocyte differentiation into tumor-associated macrophages in glioblastoma.

Related Experiment Videos

Can methotrexate reduce the renal toxicity of parenteral gold?

Related Concept Videos

Related Articles